RE: Business-News-Today.com27 Mar 2026 14:12
What a weird thing to say. Avacta are objectively in a very good place. They are increasingly showing up in very serious publications, Christina is sharing platforms and bumping shoulders with seniors executives from big pharma, the FDA has validated ava6000 through the lifting of the lifetime limit, 6103 has raced to this first in-human trial, mgmt is telling the market why pre|CISION beats multibillion dollar ADC drugs.
Commercial deals haven't been agreed on terms both parties are happy with and management think the key inflection point is 6103 data so they raise a few quid to get to that point.
After an AIM placing the share price almost always retreats to the placing price yet today it hasn't, on an absolutely terrible day for the markets. We are nearing the end game here, we're soon going to find out if pre|CISION is the real deal and today's share price action hints of what we will see in the coming weeks, a major move north.
There's a lot to be excited about.